Leishmaniasis: all 185 studies
Page 1 of 2. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With LeishmaniasisRecruitingNCT07783243
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT07358910
- Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne DiseasesNot yet recruitingNCT06859619Not applicable
- Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.RecruitingNCT06822478Phase 3
- Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)RecruitingNCT06793111
- Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in EthiopiaNot yet recruitingNCT06695143Phase 3
- Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral MiltefosineRecruitingNCT06550609Phase 2
- OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis PatientsRecruitingNCT06514560
- Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential BiomarkersRecruitingNCT06307171Not applicable
- Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the ElderlyRecruitingNCT06040489Phase 2/3
- Tofacitinib Associated With Meglumine Antimoniate in Cutaneous LeishmaniasisNot yet recruitingNCT06011343Phase 2/3
- Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous LeishmaniasisRecruitingNCT05708625Phase 3
- Clinical Prognostic Score to Predict Relapse in VLRecruitingNCT05602610
- Treatment of Mucosal Bolivian LeishmaniasisRecruitingNCT04799236Phase 3
- Pilot Study Using a Heat Pack to Treat Cutaneous LeishmaniasisAvailableNCT01277796
- Diagnosis and Treatment of Leishmania InfectionsRecruitingNCT00344188
- Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy ParticipantsTerminatedNCT04504435Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy SubjectsTerminatedNCT03874234Phase 1Results posted
- Defining Skin Immunity of a Bite of Key Insect Vectors in HumansCompletedNCT03641339Not applicableResults posted
- Evaluation of CL Detect™ Rapid Test to Detect Cutaneous LeishmaniasisCompletedNCT01865032Results posted
- Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in PanamaCompletedNCT01790659Phase 3Results posted
- Evaluation of a Rapid Diagnostic Device, CL Detect, for the Diagnosis of Cutaneous Leishmaniasis in TunisiaCompletedNCT01769612Results posted
- A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous LeishmaniasisCompletedNCT01536795Phase 2Results posted
- WR 279,396 Open Label Treatment Protocol in TunisiaTerminatedNCT01494350Phase 2Results posted
- Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort StudyCompletedNCT01360762Phase 3Results posted
- Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous LeishmaniasisTerminatedNCT01140191Phase 2Results posted
- Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in PanamaCompletedNCT01083576Phase 2Results posted
- Miltefosine to Treat Mucocutaneous LeishmaniasisCompletedNCT01050907Phase 2Results posted
- Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)CompletedNCT01032382Phase 2Results posted
- A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous LeishmaniasisCompletedNCT01011309Phase 2Results posted
- Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous LeishmaniasisCompletedNCT00884377Phase 2Results posted
- Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old WorldCompletedNCT00703924Phase 2Results posted
- Sodium Stibogluconate Treatment of LeishmaniasisCompletedNCT00662012Phase 2Results posted
- Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396TerminatedNCT00657917Phase 2Results posted
- Use of Sodium Stibogluconate as a Treatment for LeishmaniasisCompletedNCT00657618Phase 1/2Results posted
- Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test AntigenCompletedNCT00633009Phase 2Results posted
- Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)CompletedNCT00606580Phase 3Results posted
- Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.CompletedNCT00471705Phase 3Results posted
- Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the DiseaseCompletedNCT06692985
- Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the ElderlyCompletedNCT06449040Phase 1/2
- Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy AdultsTerminatedNCT06124144Phase 1
- Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation StudyTerminatedNCT06118749
- Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.CompletedNCT06000514Phase 1/2
- Feasibility and Usability of Mobile Applications for Monitoring Cutaneous Leishmaniasis Treatment in ColombiaCompletedNCT05533736Not applicable
- Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective StudyStatus unknownNCT05493059
- Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South SudanCompletedNCT05449717
- Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of CureCompletedNCT05426577
- Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in KenyaStatus unknownNCT05386875
- Spatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in EthiopiaCompletedNCT05332093
- Arnica Tincture Fot the Treatment of Cutaneous LeishmaniasisActive, not recruitingNCT05094908Phase 1
- Investigation of an Outbreak Situation of Cutaneous Leishmaniasis Among Military Personnel in French Guiana (CEFELEISH)CompletedNCT04888130
- Development of Topical Herbal Formulations for Treatment of Cutaneous LeishmaniasisCompletedNCT04841239Not applicable
- Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in EthiopiaCompletedNCT04699383
- Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New WorldCompletedNCT04515186Phase 3
- A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand FliesCompletedNCT04512742Not applicable
- Performance of RPA-LF for Cutaneous LeishmaniasisCompletedNCT04500873
- Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL)CompletedNCT04340128Phase 3
- A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)WithdrawnNCT04107961Phase 2
- Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis.WithdrawnNCT04072874Phase 1/2
- Outcomes of Complicated CL in Ethiopia Treated With MiltefosineCompletedNCT04004754
- LAMP Assay for the Diagnosis of Visceral LeishmaniasisCompletedNCT04003532
- Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in BelgiumTerminatedNCT04001335
- A Clinical Study to Develop an Uninfected Sand Fly Biting ProtocolCompletedNCT03999970Not applicable
- Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART CentreCompletedNCT03993093
- A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDLCompletedNCT03969134Phase 2
- Single Oral Dose Escalation Study of DNDI-0690 in Healthy SubjectsCompletedNCT03929016Phase 1
- Cutaneous Leishmaniasis Diagnostic StudyCompletedNCT03837431
- Oral Miltefosine Plus Topical Paromomycin In American Cutaneous LeishmaniasisCompletedNCT03829917Phase 2/3
- Mediterranean Visceral Leishmaniasis With Leishmania InfantumActive, not recruitingNCT03784248
- Evaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in PeruStatus unknownNCT03762070
- Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern AfricaCompletedNCT03646981
- Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed ConditionCompletedNCT03636659Phase 1
- Miltefosine Plus IL Pentamidine for Bolivian CLCompletedNCT03445897Phase 2
- Evaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in AfghanistanCompletedNCT03435419
- Short Course Regimens for Treatment of PKDL (Sudan)Status unknownNCT03399955Phase 2
- Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in BangladeshCompletedNCT03311607Phase 4
- ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -CompletedNCT03303898Not applicable
- Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous LeishmaniasisCompletedNCT03294161Phase 2
- Improved Case Detection and Vector Control for Visceral LeishmaniasisCompletedNCT03269006Not applicable
- Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, PakistanTerminatedNCT03208543Phase 3
- Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern AfricaCompletedNCT03129646Phase 3
- Topical Paromomycin for Cutaneous Leishmaniasis in BoliviaCompletedNCT03096457Phase 2/3
- Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis PatientsStatus unknownNCT03084952Phase 2
- Miltefosine and GM-CSF in Cutaneous LeishmaniasisCompletedNCT03023111Phase 3
- Predicting Visceral Leishmaniasis in HIV Infected PatientsTerminatedNCT03013673
- Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.Status unknownNCT03009422Not applicable
- Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in MoroccoCompletedNCT02979002
- Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. GuyanensisCompletedNCT02919605Phase 2
- A Study of a New Leishmania Vaccine Candidate ChAd63-KHCompletedNCT02894008Phase 2
- Asymptomatic Leishmania Infection in HIV PatientsTerminatedNCT02839603
- Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨CompletedNCT02687971Phase 2
- Topical Liposomal Amphotericin B Gel Treatment for Cutaneous LeishmaniasisCompletedNCT02656797Phase 2
- The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in BrazilActive, not recruitingNCT02530697Phase 2
- Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous LeishmaniasisCompletedNCT02431429
- Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern AfricaCompletedNCT02431143Phase 2
- Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous LeishmaniasisCompletedNCT02429518
- Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient RegistryWithdrawnNCT02429505
- Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy RegistryWithdrawnNCT02427308
- Miltefosine for Children With PKDLCompletedNCT02193022Phase 3
- Visceral Leishmaniasis and Malnutrition in Amhara Regional State, EthiopiaCompletedNCT02148822